Adjuvant Everolimus Fails to Stop Recurrence in Early High-Risk Breast Cancer

More than half of everolimus-treated patients permanently discontinued treatment

Related Keywords

France ,London ,City Of ,United Kingdom ,Singapore ,Peter Schmid ,Charles Bankhead ,European Society For Medical Oncology ,Leon Berard Center ,Barts Center ,National Cancer Center Singapore ,Thomas Bachelot ,European Society ,Medical Oncology ,Rebecca Dent ,Medpage Today ,